Mitchell Mathis

650 total citations
15 papers, 292 citations indexed

About

Mitchell Mathis is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Economics and Econometrics. According to data from OpenAlex, Mitchell Mathis has authored 15 papers receiving a total of 292 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Psychiatry and Mental health, 6 papers in Pediatrics, Perinatology and Child Health and 6 papers in Economics and Econometrics. Recurrent topics in Mitchell Mathis's work include Health Systems, Economic Evaluations, Quality of Life (6 papers), Pharmaceutical studies and practices (6 papers) and Schizophrenia research and treatment (6 papers). Mitchell Mathis is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (6 papers), Pharmaceutical studies and practices (6 papers) and Schizophrenia research and treatment (6 papers). Mitchell Mathis collaborates with scholars based in United States, India and Germany. Mitchell Mathis's co-authors include Peiling Yang, Ellis F. Unger, Thomas Laughren, Tiffany Farchione, Thomas Pohlmann, Ni A. Khin, Paul A. David, Yeh‐Fong Chen, Robert J. Temple and Ramana Uppoor and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Clinical Pharmacology & Therapeutics.

In The Last Decade

Mitchell Mathis

15 papers receiving 284 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mitchell Mathis United States 10 114 105 53 37 31 15 292
Olubanke Olofinjana United Kingdom 7 195 1.7× 79 0.8× 50 0.9× 30 0.8× 24 0.8× 8 322
Shubhra Mace United Kingdom 9 277 2.4× 125 1.2× 49 0.9× 33 0.9× 38 1.2× 14 467
Rafał Jaeschke Poland 11 189 1.7× 63 0.6× 37 0.7× 39 1.1× 25 0.8× 27 409
Pedro Such Denmark 11 307 2.7× 135 1.3× 64 1.2× 30 0.8× 59 1.9× 32 486
Tanya Ramey United States 8 114 1.0× 126 1.2× 100 1.9× 39 1.1× 18 0.6× 13 370
Tayfun Turan Türkiye 10 166 1.5× 82 0.8× 31 0.6× 40 1.1× 26 0.8× 22 340
Rocco Nicola Forgione Italy 10 266 2.3× 118 1.1× 75 1.4× 31 0.8× 21 0.7× 12 440
Goran Eryavec Canada 12 237 2.1× 76 0.7× 21 0.4× 29 0.8× 31 1.0× 17 422
Christian G. Widschwendter Austria 10 211 1.9× 42 0.4× 36 0.7× 69 1.9× 18 0.6× 19 328
C. Bruce Baker United States 9 135 1.2× 70 0.7× 34 0.6× 40 1.1× 26 0.8× 12 349

Countries citing papers authored by Mitchell Mathis

Since Specialization
Citations

This map shows the geographic impact of Mitchell Mathis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitchell Mathis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitchell Mathis more than expected).

Fields of papers citing papers by Mitchell Mathis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mitchell Mathis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitchell Mathis. The network helps show where Mitchell Mathis may publish in the future.

Co-authorship network of co-authors of Mitchell Mathis

This figure shows the co-authorship network connecting the top 25 collaborators of Mitchell Mathis. A scholar is included among the top collaborators of Mitchell Mathis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mitchell Mathis. Mitchell Mathis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Gopalakrishnan, Mathangi, Hao Zhu, Tiffany Farchione, et al.. (2020). The Trend of Increasing Placebo Response and Decreasing Treatment Effect in Schizophrenia Trials Continues. The Journal of Clinical Psychiatry. 81(2). 19 indexed citations
2.
Gopalakrishnan, Mathangi, Tiffany Farchione, Mitchell Mathis, et al.. (2020). Shortened Positive and Negative Symptom Scale as an Alternate Clinical Endpoint for Acute Schizophrenia Trials: Analysis from the US Food & Drug Administration. SHILAP Revista de lepidopterología. 3(1). 38–45. 1 indexed citations
3.
Farchione, Tiffany, Mitchell Mathis, Mathangi Gopalakrishnan, et al.. (2020). Assessment of Similarity in Antipsychotic Exposure‐Response Relationships in Clinical Trials Between Adults and Adolescents With Acute Exacerbation of Schizophrenia. The Journal of Clinical Pharmacology. 60(7). 848–859. 7 indexed citations
4.
Younis, Islam R., Mathangi Gopalakrishnan, Mitchell Mathis, et al.. (2020). Association of End Point Definition and Randomized Clinical Trial Duration in Clinical Trials of Schizophrenia Medications. JAMA Psychiatry. 77(10). 1064–1064. 12 indexed citations
5.
Zhu, Hao, Tiffany Farchione, Mitchell Mathis, et al.. (2019). A Quantitative Justification of Similarity in Placebo Response Between Adults and Adolescents With Acute Exacerbation of Schizophrenia in Clinical Trials. Clinical Pharmacology & Therapeutics. 106(5). 1046–1055. 8 indexed citations
6.
Lee, Daniel J., et al.. (2018). US Food and Drug Administration’s Approval of Aripiprazole Tablets With Sensor. The Journal of Clinical Psychiatry. 79(3). 4 indexed citations
7.
Mathis, Mitchell, et al.. (2017). The US Food and Drug Administration’s Perspective on the New Antipsychotic Pimavanserin. The Journal of Clinical Psychiatry. 78(6). e668–e673. 29 indexed citations
8.
Li, Liang, Yaning Wang, Ramana Uppoor, et al.. (2017). Exposure–response analyses of blood pressure and heart rate changes for methylphenidate in healthy adults. Journal of Pharmacokinetics and Pharmacodynamics. 44(3). 245–262. 11 indexed citations
9.
Davis, Michael C., et al.. (2017). Efficient Trial Design — FDA Approval of Valbenazine for Tardive Dyskinesia. New England Journal of Medicine. 376(26). 2503–2506. 17 indexed citations
10.
Khin, Ni A., Phillip D. Kronstein, Peiling Yang, et al.. (2015). Regulatory and Scientific Issues in Studies to Evaluate Sexual Dysfunction in Antidepressant Drug Trials. The Journal of Clinical Psychiatry. 76(8). 1060–1063. 14 indexed citations
11.
Chen, Yeh‐Fong, Thomas Laughren, Paul A. David, et al.. (2014). Review of Maintenance Trials for Major Depressive Disorder. The Journal of Clinical Psychiatry. 75(3). 205–214. 88 indexed citations
12.
Zhang, Jing, Mitchell Mathis, André J. Jackson, et al.. (2014). The US Food and Drug Administration’s Perspective on the New Antidepressant Vortioxetine. The Journal of Clinical Psychiatry. 76(1). 8–14. 26 indexed citations
13.
Mathis, Mitchell & Thomas Pohlmann. (2014). Projection of physical conditions in the North Sea for the 21st century. Climate Research. 61(1). 1–17. 26 indexed citations
14.
Younis, Islam R., Thomas Laughren, Yaning Wang, Mitchell Mathis, & Jogarao Gobburu. (2013). An Integrated Approach for Establishing Dosing Recommendations. Journal of Clinical Psychopharmacology. 33(2). 152–156. 4 indexed citations
15.
Rogers, Hobart, Atul Bhattaram, Issam Zineh, et al.. (2012). CYP2D6 Genotype Information to Guide Pimozide Treatment in Adult and Pediatric Patients. The Journal of Clinical Psychiatry. 73(9). 1187–1190. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Olubanke Olofinjana Breakdown of academic impact, for papers by Shubhra Mace Breakdown of academic impact, for papers by Rafał Jaeschke Breakdown of academic impact, for papers by Pedro Such Breakdown of academic impact, for papers by Tanya Ramey Breakdown of academic impact, for papers by Tayfun Turan Breakdown of academic impact, for papers by Rocco Nicola Forgione Breakdown of academic impact, for papers by Goran Eryavec Breakdown of academic impact, for papers by Christian G. Widschwendter Breakdown of academic impact, for papers by C. Bruce Baker
Rankless by CCL
2026